MedTrace Logo

Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication

NCT02472782 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 851

Last updated 2019-01-10

No results posted yet for this study

Summary

This is a study aiming to investigate a possible correlation between the parameters affecting the physicians' therapeutic choice with the patients' overall adherence to osteoporosis treatment. Secondary end-points include correlation between the parameters affecting the physicians' therapeutic choice and the patients' quality of life as well as the evaluation of the whole osteoporosis treatment approach of orthopedic surgeons in Greece (diagnostic means, use of diagnostic and treatment guidelines, methodology of follow - up).

Conditions

  • Osteoporosis, Postmenopausal
  • Osteoporosis, Steroid Induced

Interventions

DRUG

Teriparatide

The study will include patients from pre-defined groups of individuals (postmenopausal, male, and steroid-induced osteoporosis) who would any way receive teriparatide for their condition according to standard medical practice and Greek treatment guidelines

Sponsors & Collaborators

  • Hellenic Osteoporosis Foundation (www.http://heliost.gr/en/)

    collaborator UNKNOWN

  • 251 Hellenic Air Force & VA General Hospital

    lead OTHER

Principal Investigators

  • George Lyritis, Professor · Hellenic Osteoporosis Foundation

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-06-30
Completion
2018-12-15

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02472782 on ClinicalTrials.gov